Case Study: Clinical-Stage Biotech Company Lyell achieves 50% licensing cost savings and full SaaS visibility with Axonius SaaS Management

How A Clinical-stage Biotech Company Enhanced Saas Visibility Using Axonius Saas Management

Clinical-Stage Biotech Company, a developer of adoptive cellular therapies, faced rapid SaaS adoption that left IT without visibility into what apps and licenses were in use, creating cost, duplication and security risks (including exposed API keys and misconfigurations). To address these challenges they turned to Axonius and its Axonius SaaS Management solution.

Axonius SaaS Management was deployed to discover and inventory the company’s ~140 apps, integrate key services, and build tailored views for IT and business leaders. Axonius uncovered misconfigurations and an exposed API key, exposed underused licenses (enabling a 50% reduction in licensing costs for a major app), and improved cross‑department collaboration and configuration best practices — strengthening both cost control and security posture.